VitaDX
VitaDX's medical software uses fluorescence imaging and machine learning for early bladder cancer diagnosis.
France
26 employees
Debt Financing
Total: $4.72M
AI, Biotechnology
General Information
France
BounceWatch is an independent company data service, not affiliated with VitaDX. To contact VitaDX, visit vitadx.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does VitaDX compare?
A PDF of VitaDX and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting VitaDX soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About VitaDX
Business keywords: medical imaging, fluorescence imaging, early cancer diagnosis, bladder cancer, clinical testing, CE marking, University collaboration
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | €1.00M | 2 |
|
04 Sep 2020 |
| Debt Financing | €2.00M | 4 |
|
04 Sep 2020 |
| Seed Round | €1.60M | 2 |
|
06 Jun 2017 |
| Pre Seed Round | €120.00K | 1 |
|
04 Dec 2014 |
VitaDX Alternatives & Competitors
View All Alternatives
Neurabot Lab is digital laboratory 4.0 platform and fighting cancer by AI technology in computationa...
Our mission is to enable personalised cancer treatment through AI tissue diagnostics
Qritive makes cancer diagnostics fast, accurate, and affordable
FAQ About VitaDX
Source: BounceWatch company record for VitaDX, https://bouncewatch.com/company/vitadx, updated 29 December 2024. When citing, please name BounceWatch and link this page.
